FiercePharma

PARI snags FDA approval for cystic fibrosis nebulizer platform

Respiratory devicemaker PARI picked up an approval from the FDA for its eRapid nebulizer system, which is the first electronic one to deliver Genentech's cystic fibrosis treatment Pulmozyme. A ...
Finanznachrichten

PARI Pharma's eFlow Technology device, LAMIRA, approved as the only nebulizer system to deliver Insmed's ARIKAYCE (amikacin liposome inhalation suspension)

- ARIKAYCE is the First and Only Therapy Specifically Indicated for the Treatment of Mycobacterium Avium Complex (MAC) Lung Disease in Adult Patients with Limited or No Alternative Treatment Options - ...

A nebulizer is a device used to treat conditions like asthma — here's how to use one

A nebulizer is a machine that turns liquid medication into an inhalable mist and is used for people with respiratory conditions.
Business Insider

PARI Nebulizer Used in New Study with Pulmotect's Inhaled PUL-042 for COVID-19

MIDLOTHIAN, Va., May 7, 2020 /PRNewswire/ -- This week, the first patients are enrolling in two phase 2 clinical trials for COVID-19 using Pulmotect's PUL-042, an inhaled immunomodulatory agent to ...